Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210038113 210008974 1.15 19.3 Disease modification (D) null 2019-03-12 Carboplatin AUC 2 - 5 N N 210017129 CARBOPLATIN
210038114 210008994 1.74 93.5 Curative (C) 2015-02-01 2015-10-04 Procarbazine N N 210017201 PROCARBAZINE
210038115 210009038 0 74.7 Curative (C) 2017-06-03 2017-08-07 IDELALISIB 01 N 210017421 NELARABINE
210038116 210019717 null 67.2 Curative (C) 2017-04-19 2017-11-14 Pentostatin N N 210017422 BEVACIZUMAB
210038117 210009118 1.67 70.8 Curative (C) 2015-11-17 2015-11-22 CHOP - 21 days N N 210017673 METHOTREXATE HIGH DOSE
210038118 210009283 null 96 Palliative (P) null 2017-07-19 CHLORAMBUCIL + OFATUMUMAB Y N 210018278 UKALL XII
210038119 210030811 null null Curative (C) 2018-11-11 2018-12-31 Bendamustine +/- Prednisolone N N 210018518 CHLORAMBUCIL + OFATUMUMAB
210038120 210009736 0 72 Curative (C) 2017-10-30 2017-12-04 CNS LGG 2004 03 vinc weekly+ carbo Y N 210019691 CARBOPLATIN + VINCRISTINE
210038121 210036061 0.87 14.8 Curative (C) 2019-10-21 2019-10-21 CHOP - 21 days N N 210021334 CYCLOPHOSPHAMIDE + VINCRISTINE
210038122 210010255 1.72 null Palliative (P) 2015-02-28 2015-07-30 Cyclophosphamide + Vincristine N N 210021606 RIALTO TRIAL
210038123 210010465 1.86 16.6 Curative (C) 2019-06-27 2019-06-30 Cyclophosphamide+Fludara+TBI Allo N N 210023222 CYCLOPHOSPHAMIDE + FLUDARABINE
210038124 210036861 1.08 85.2 Curative (C) 2016-10-02 2016-10-02 AML 19 TRIAL Y null 210025775 SIOP
210038125 210021031 null null Curative (C) 2018-08-20 2018-08-30 FLUDARABINE N null 210027027 BR14 TRIAL
210038126 210010805 1.72 68.8 Curative (C) 2016-10-26 2016-11-24 CARBOPLATIN + ETOPOSIDE + VINCRISTINE SULPHATE N N 210027036 HCX
210038127 210010853 1.78 79.4 Palliative (P) 2015-09-05 2015-11-28 Irinotecan + Temozolomide N N 210027335 SIOP
210038128 210010868 null 101 Curative (C) 2019-12-02 2020-03-20 Cytarabine low (10to20mg/m2) IV/SC N N 210027506 TRASTUZUMAB
210038129 210010875 null 69 Palliative (P) 2017-06-01 2017-09-23 BEAM N N 210027529 BEVACIZUMAB + IRINOTECAN
210038130 210011304 null 102.6 Disease modification (D) 2016-12-13 2016-12-18 Bevacizumab + LOMUSTINE N N 210029102 BEVACIZUMAB + TEMOZOLOMIDE
210038131 210021593 1.02 10.5 Curative (C) 2017-08-03 2017-08-07 ALEMTUZUMAB + BUSULFAN + FLUDARABINE N null 210032019 BEVACIZUMAB + IRINOTECAN
210038132 210011928 null 74 Curative (C) 2014-07-02 2014-07-05 IDARUBICIN N Y 210032021 ICE
210038133 210012142 1.69 null Curative (C) 2015-08-05 2015-08-07 AML16 DA 3+8 1 Y 210033299 CYCLET
210038134 210012157 null 66.599 Neo-adjuvant (N) 2016-03-30 2016-06-30 TAMIGA trial 02 N 210033375 ABVD
210038135 210012303 1.64 null Curative (C) 2017-10-26 2018-06-30 BR14 TRIAL Y N 210034037 BEVACIZUMAB + TEMOZOLOMIDE
210038136 210012320 null 72.9 Curative (C) 2018-07-25 2018-07-25 FLAG Y Y 210034115 CARBOPLATIN + ETOPOSIDE + VINCRISTINE
210038137 210012343 1.61 null Curative (C) 2019-07-05 2019-11-01 Ofatumumab Loading 02 N 210034234 TAMIGA TRIAL
210038138 210012397 0 108.5 Adjuvant (A) 2020-10-24 2020-10-31 CYCLOPHOSPHAMIDE + ETOPOSIDE + VINCRISTINE Y N 210034702 CAPECITABINE
210038139 210022068 null null Palliative (P) 2014-10-24 2014-10-24 Nilotinib N N 210037370 CARBOPLATIN + LOMUSTINE + VINCRISTINE
210038140 210012846 1.66 55.3 Curative (C) 2018-03-04 2018-10-07 ECX N N 210037617 CISPLATIN
210038141 210012986 1.58 91.2 Disease modification (D) 2016-12-07 2017-06-14 Fludarabine IV N N 210038312 TRASTUZUMAB
210038142 210013147 1.86 75.6 Curative (C) 2020-07-25 2020-07-26 IVAC N null 210039036 CLARITY TRIAL
210038143 210028053 1.63 70 Curative (C) null 2018-07-21 CARBOPLATIN + Procarbazine Y N 210040628 CVP
210038144 210013494 1.73 66.599 Disease modification (D) 2015-12-03 2015-12-11 DOCETAXEL + PERTUZUMAB + TRASTUZUMAB N N 210041021 CYCLET
210038145 210022532 1.6 41.2 Curative (C) 2019-05-12 2019-05-30 Cyclophosphamide High Dose 02 Y 210042069 EPIRUBICIN
210038146 210013789 1.68 null Curative (C) 2019-07-24 2019-07-24 DA 3 + 10 Y N 210028705 CISPLATIN + GEMCITABINE
210038147 210014053 1.67 82.3 Curative (C) 2020-02-18 2020-04-28 CLARITY Trial N N 210041781 CYTARABINE INTRATHECAL
210038148 210004305 1.65 43.8 Palliative (P) 2015-09-20 2015-09-20 TEMOZOLOMIDE N N 210000122 TEMOZOLOMIDE
210038151 210004761 null null Curative (C) 2018-02-27 2018-05-22 Temozolomide 200mg/m2 N null 210002776 TEMOZOLOMIDE
210038152 210017530 1.61 null Adjuvant (A) 2018-04-14 2018-05-14 Temozolomide 200mg/m2 N N 210004002 TEMOZOLOMIDE
210038153 210005023 null 88 Curative (C) 2016-12-11 2017-02-25 Temozolomide 200mg/m2 N Y 210004223 TEMOZOLOMIDE
210038154 210005062 1.44 15.3 Curative (C) 2017-10-22 2018-08-13 ALL UKALL2011 Maintenance A1 Y N 210004402 UKALL2011
210038155 210017578 null 32.6 Curative (C) 2014-07-16 2015-01-28 ALL UKALL2011 Del Int C Recon PAsp Y N 210004493 UKALL2011
210038156 210017581 1.76 105 Curative (C) 2016-04-13 2017-03-30 ALL UKALL2011 Del Int A Pt1 (PAsp) Y N 210004496 UKALL2011
210038157 210029670 null 15.9 Curative (C) 2017-04-22 2018-01-14 ALL UKALL2011 Maintenance A1 1 N 210004715 UKALL2011
210038158 210032632 null 21.2 Curative (C) 2017-05-23 2017-06-06 ALL UKALL2011 Maintenance A3 Y null 210004847 UKALL2011
210038159 210005177 0.71 41.6 Curative (C) 2018-05-18 2018-08-28 ALL UKALL2011 Std Int Maint A Y null 210005122 UKALL2011
210038160 210017633 1.76 56.5 Curative (C) 2014-02-13 2014-09-23 ALL UKALL2011 Del Int C Recon PAsp N N 210005131 UKALL2011
210038161 210017640 0 14.7 Curative (C) 2014-09-22 2015-01-31 ALL UKALL2011 (ProtM-A) C PegAsp Y N 210005198 UKALL2011
210038162 210005231 null 11.9 Curative (C) 2015-11-30 2016-07-23 ALL UKALL2011 Maintenance C1 Y N 210005288 UKALL2011
210038163 210005236 null 14.8 Curative (C) 2015-01-11 2015-06-06 ALL UKALL2011 Cap Int Maint C PAsp Y N 210005293 UKALL2011
210038164 210017661 0 23.1 null 2018-08-06 2018-08-20 ALL UKALL2011 Del Intens B Pt2 null N 210005410 UKALL2011